MADISON CHASTAIN: Open Payments
NPI 1952073330 · SHEFFIELD, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,397 in 121 payments from 12 companies in 2025. Trend: 2023 $3,361 · 2024 $2,987 · 2025 $2,397
Food & beverage: $2,397
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $532 |
| Novartis Pharmaceuticals Corporation | 29 | $476 |
| AstraZeneca Pharmaceuticals LP | 10 | $329 |
| Amgen Inc. | 18 | $300 |
| UCB, Inc. | 14 | $248 |
| Janssen Biotech, Inc. | 9 | $192 |
| GlaxoSmithKline, LLC. | 6 | $125 |
| Organon LLC | 4 | $77 |
| PFIZER INC. | 3 | $59 |
| Fresenius Kabi USA, LLC | 1 | $24 |
Products named: COSENTYX, RINVOQ, SAPHNELO, Bimzelx, TREMFYA, SKYRIZI, BENLYSTA, HADLIMA.
Industry payments across AL — which companies pay providers there.
